-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Reiterates Outperform on Abbott Laboratories, Maintains $147 Price Target

Benzinga·10/16/2025 13:59:19
Listen to the news
RBC Capital analyst Shagun Singh reiterates Abbott Laboratories (NYSE:ABT) with a Outperform and maintains $147 price target.